Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$522.38 +6.04 (+1.17%)
At close: Sep 24, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Payables (2009 - 2026)

Vertex Pharmaceuticals (VRTX) posted Payables of $429.5 million for Q2 2026, down 12.22% on a QoQ basis from $489.3 million in Q1 2026, and down 2.89% year-over-year from $442.3 million in Q2 2025.

Analysis

Vertex Pharmaceuticals (VRTX) Payables (2009 - 2026) Analysis & Trends

Vertex Pharmaceuticals has reported Payables for 18 years, with the latest figure at $429.5 million in Q2 2026.

  • On a quarterly basis, Payables fell 2.89% year-over-year to $429.5 million in Q2 2026; TTM through Jun 2026 was $429.5 million, a 2.89% decrease from a year earlier, with the FY2025 full-year figure at $461.7 million, up 11.79% from the prior year.
  • Payables was $429.5 million for Q2 2026 at Vertex Pharmaceuticals, down from $489.3 million in the prior quarter.
  • The five-year high for Payables was $489.3 million in Q1 2026, with the low at $126.9 million in Q3 2022.
  • Average Payables over 5 years is $355.9 million, with a median of $370.4 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2024: Payables soared 196.22% in 2023, then slipped 9.67% in 2024.
  • Over 5 years, Payables stood at $303.9 million in 2022, then advanced by 20.07% to $364.9 million in 2023, then climbed by 13.18% to $413.0 million in 2024, then rose by 11.79% to $461.7 million in 2025, then retreated by 6.97% to $429.5 million in 2026.
  • The last three Payables figures came in at $429.5 million (Q2 2026), $489.3 million (Q1 2026), and $461.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 20.92 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 33.30 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 5.96 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -22.89 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 674.00 Mn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 7.03 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 429.50 Mn
10 Bristol Myers Squibb 124.95 Bn 113.89 Bn 9.25 Bn 4.16 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 429.50 Mn
Mar 31, 2026 489.30 Mn
Dec 31, 2025 461.70 Mn
Sep 30, 2025 420.30 Mn
Jun 30, 2025 442.30 Mn
Mar 31, 2025 445.00 Mn
Dec 31, 2024 413.00 Mn
Sep 30, 2024 395.80 Mn
Jun 30, 2024 327.90 Mn
Mar 31, 2024 351.40 Mn
Dec 31, 2023 364.90 Mn
Sep 30, 2023 375.90 Mn
Jun 30, 2023 363.00 Mn
Mar 31, 2023 323.20 Mn
Dec 31, 2022 303.90 Mn
Sep 30, 2022 126.90 Mn
Jun 30, 2022 198.00 Mn
Mar 31, 2022 173.60 Mn
Dec 31, 2021 195.00 Mn
Sep 30, 2021 127.86 Mn
API Access

Vertex Pharmaceuticals Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=VRTX&period=max&api_key=YOUR_API_KEY